Miranda Neville

Vice President Global Operations & Delivery • Autolus

Miranda Neville, Autolus VP of Global Operations & Delivery has been in the biotech/pharmaceutical industry for the last 23 years. She started her career at Human Genome Sciences in the early 2000s, as the genome mapping was underway, and drugs were being developed with this new technology. Following HGS, she spent several years as a partner at consulting firm AllianceBio. In 2018, her interest in cell & gene therapy led her to join Autolus, a CAR-T cell therapy company. Most of her career has been focused on engineering & capital projects, and project management. Today she leads Engineering & Capital projects team, EH&S, Procurement, Logistics and Patient Scheduling departments for Autolus

Also Speaking

Amy DuRoss

President, Cell and Gene Therapy • CSafe

Jacob Becraft

Co-Founder & CEO • Strand Therapeutics

Ian Gaudet

Senior Director, Site Head San Jose • Miltenyi Biotec

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.